Global Consortium, Inc. Announces Expansion
by Building a CBD Processing Lab, increasing harvest
revenues to $4,000,000.
-
The lab will increase the revenue to $4,000,0000 from the
harvest
-
The lab will run all year round and process biomass for
other farms
Coconut Creek, FL -- November
07, 2018 -- InvestorsHub NewsWire -- Global Consortium, Inc.,
(OTCPINK:
BDCI) is pleased to announce the
Company is building a processing lab in its 10,000
sq. ft.
barn in
Colorado.
A 2,000 sq. ft. section will be
designated
to convert the
plants into CBD Isolate.
Currently,
the demand
for CBD far outweighs its availability.
Prices range from
$7,500/kg to over $9,000/kg depending on the amount being
purchased.
The biomass from the farm
would have yielded around $950,000 to $1 million. With the addition of the
lab, the
same crop should yield $4,000,000 or
more.
The
revenue will still show on the 4th quarter report.
Global will keep a portion of
the Isolate for its own needs and sell the balance on the open
market.
Building a lab for CBD in
CO is an
excellent choice since the crop is
already
located
there. There are also additional CBD farms
in the
surrounding area that will need
processing. The current license allows for
the processing of the CBD into Isolate.
The lab added to the farm turns the
farm into a multiple source of revenue
streams:
Biomass,
CBD Isolate and 3rd party processing.
Bahamas Development
Corporation, in compliance with SEC regulations, may in the future
use social media outlets like Facebook or Twitter and its own
website to announce key information in compliance with
Reg. FD.
Forward-Looking
Statements
This news release contains
"forward-looking statements" as that term is defined in Section
27(a) of the United States Securities Act of 1933, as amended and
Section 21(e) of the Securities Exchange Act of 1934, as amended.
Statements in this press release which are not purely historical
are forward-looking statements and include any statements regarding
beliefs, plans, expectations or intentions regarding the future.
Such forward-looking statements include, among other
things, estimates of services and
equipment markets, release of corporate apps, growth of platform,
target markets, product releases, product demand and, business
strategy. Actual results could differ
from those projected in any forward-looking statements due to
numerous factors. Such factors include, among others, the inherent
uncertainties associated with new projects and development stage
companies. These forward-looking statements are made as of the date
of this news release, and we assume no obligation to update the
forward-looking statements, or to update the reasons why actual
results could differ from those projected in the forward-looking
statements. Although we believe that any beliefs, plans,
expectations and intentions contained in this press release
are reasonable, there can be no
assurance that any such beliefs, plans, expectations or intentions
will prove to be accurate. Investors should consult all of the
information set forth herein and should also consider that any
investment in securities is at risk.
Details of the
Company's business, finances, appointments and agreements can be
found as part of the Company's continuous public disclosure
on otcmarkets.com.
For additional information
about this release please contact:
Investor
Relations:
Matt Dwyer
matt@cannabisconsortium.net
www.cannabisconsortium.net
Twitter:
@CannabisConsort
954-906-0098